Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Trial of Brodalumab in Palmoplantar Pustulosis
jRCT2080224783Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Jul 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Palmoplantar Pustular Psoriasis (PPPP) comparing Brodalumab arm with Placebo arm (2 arms). Started Jul 2019; status: completed.
02
Drugs
brodalumab
03
Conditions
Palmoplantar Pustular Psoriasis (PPPP)
Beyond the preview
Go deeper on jRCT2080224783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224783.